Anand Ravindran is a motivated biology leader with extensive experience in driving discovery programs for therapeutic intervention in cancer. They completed a PhD in Pathobiology at The Pennsylvania State University, where they focused on TGFβ signaling in UVB-induced inflammation and carcinogenesis. Their postdoctoral work at MedImmune and subsequent roles at GSK and AstraZeneca further developed their expertise in immunology and T cell engagers. Anand is recognized for their collaborative problem-solving skills and commitment to advancing innovative therapies for cancer patients.
This person is not in the org chart
This person is not in any teams
This person is not in any offices